Evidence map›Paper›PMID 38361892›Full record

ArticleJournal of family medicine and primary care2023

Post-COVID pulmonary fungal infections: An unanticipated predicament or a ticking time bomb? Clinico-microbiological profile of cases encountered during the second wave of COVID-19 pandemic at a teaching hospital in the Himalayas with a brief literature review.

Oshin Puri, Mohit Bhatia, Udayakumar S Rekha, Deepika Chakraborty, Ruchi Dua, Minakshi Dhar, Udit Chauhan, Amber Prasad, Deepjyoti Kalita, Neelam Kaistha

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of family medicine and primary care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Oshin PuriDepartment of Microbiology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Mohit BhatiaDepartment of Microbiology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
Udayakumar S RekhaDepartment of Microbiology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Deepika ChakrabortyDepartment of Microbiology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Ruchi DuaDepartment of Pulmonary Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Minakshi DharDepartment of Medicine, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Udit ChauhanDepartment of Radiodiagnosis, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Amber PrasadDepartment of Microbiology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Deepjyoti KalitaDepartment of Microbiology, All India Institute of Medical Sciences, Guwahati, India.
Neelam KaisthaDepartment of Microbiology, All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study attempts to generate preliminary data regarding post-COVID pulmonary fungal infections, namely, COVID-19-associated pulmonary aspergillosis (CAPA), COVID-19-associated pulmonary mucormycosis (CAPM), and mixed infections from the Himalayas and compares the micro-radio-clinical profile and outcomes of the affected patients. Materials and Methods: A retrospective data analysis was conducted, where clinical profiles, microbiological and radiological reports, and outcomes of Results: Of Conclusion: The immuno-compromised state following COVID-19 infection and treatment might be responsible for the progression of regular exposure to the dense Himalayan vegetation into an invasive pulmonary fungal infection. Suspecting post-COVID pulmonary fungal infection is necessary for primary care physicians to ensure timely referral to higher centers. Mixed pulmonary fungal infections (coinfection with

Indexed as

COVID-19COVID-19-associated pulmonary aspergillosis (CAPA)COVID-19-associated pulmonary mucormycosis (CAPM)mixed pulmonary fungal infection

Identifiers

PMID38361892
PMCPMC10866219

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.